Autolus Therapeutics PLC
F:6A3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Autolus Therapeutics PLC
F:6A3A
|
UK |
|
S
|
Spacetalk Ltd
F:EZY
|
AU |
|
G
|
Great Eagle Holdings Ltd
F:GHK
|
BM |
|
C
|
Coxem Co Ltd
KOSDAQ:360350
|
KR |
|
Pentanet Ltd
F:83K
|
AU |
|
D
|
DHSteel
KOSDAQ:021040
|
KR |
|
A
|
Aiji Net Inc
KOSDAQ:462980
|
KR |
|
R
|
Redox Ltd
ASX:RDX
|
AU |
|
W
|
Webuild SpA
OTC:IMPJY
|
IT |
|
A
|
AnGes Inc
XMUN:AJW
|
JP |
|
S
|
Strategic Energy Resources Ltd
F:EB8
|
AU |
|
FG Nexus Inc
NASDAQ:FGNX
|
US |
|
Big Medya Teknoloji AS
IST:BIGTK.E
|
TR |
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
|
P
|
Progress Software Corp
F:PGR
|
US |
|
C
|
Cassiar Gold Corp
OTC:CGLCF
|
CA |
|
G
|
Gree Inc
F:V3U
|
JP |
|
T&D Holdings Inc
OTC:TDHOF
|
JP |
|
Intouch Insight Ltd
XTSX:INX
|
CA |
|
River Tech plc
F:9YQ
|
MT |
|
Rural Funds Group
F:J19
|
AU |
|
B
|
BW LPG Ltd
XMUN:BW9
|
SG |
|
O
|
Ocado Group PLC
F:0OC
|
UK |
|
Artmarket.com SA
PAR:PRC
|
FR |
Bankruptcy Probability
Autolus Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Autolus Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
471.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Autolus Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Autolus Therapeutics PLC has total debt of 271.4m USD. This includes both short-term (0 USD) and long-term (271.4m USD) debt.
You can find a full breakdown on its Balance Sheet.